Table 1.
Enteric pathogens in stool samples obtained from children without diarrhea, by treatment group.
| No. (%) of samples | ||
|---|---|---|
| Pathogen | Lactoferrin supplementation group (n =146) | Placebo group (n =174) |
| Bacteria | ||
| Shigella flexneri | 1 (0.7) | 2 (1.1) |
| Salmonella species | 0 (0) | 2 (1.1) |
| Campylobacter species | 0 (0) | 1 (0.6) |
| Enteroaggregative Escherichia coli | 16 (11.0) | 17 (9.8) |
| Enteropathogenic E. coli | 16 (11.0) | 16 (9.2) |
| Diffusely adherent E. coli | 10 (6.8) | 11 (6.3) |
| Enterotoxigenic E. coli | 3 (2.1) | 6 (3.4) |
| Shiga toxin–producing E. coli | 0 (0) | 1 (0.6) |
| Diarrhea-associated parasites | ||
| Giardia lambliaa | 14 (9.6) | 30 (17.2) |
| Cryptosporidium species | 2 (1.4) | 0 (0) |
| Cyclospora cayetanensis | 0 (0) | 1 (0.6) |
| Balantidium coli | 1 (0.7) | 0 (0) |
| Other parasitesb | 32 (21.9) | 37 (21.3) |
NOTE. There were multiple mixed infections; therefore, the total number of samples is greater than the specified n value.
a
P<.05.
b
Other parasite included Blastocystis hominis, Ascaris lumbricoides, Trichuris trichiura, Isospora belli, Chilomastix mesnili, Endolimax nana, and Enterobius vermicularis.